# Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes

> **NCT05907850** · EARLY_PHASE1 · COMPLETED · sponsor: **Steven Moore** · enrollment: 150 (actual)

## Conditions studied

- Muscle Soreness

## Interventions

- **DRUG:** Riboflavin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05907850
- **Lead sponsor:** Steven Moore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-23
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05907850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05907850, "Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05907850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*